Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $124.98 | 1 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $124.98 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $124.98 | 1 | PFIZER INC. ($124.98) |
All Payment Transactions
1 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 951 | 1,384 | $311,815 | $39,353 |
| 2022 | 13 | 1,241 | 1,877 | $418,521 | $53,895 |
| 2021 | 7 | 288 | 426 | $78,182 | $12,283 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 148 | 171 | $43,549 | $11,098 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 238 | 260 | $43,329 | $10,491 | 24.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 173 | 185 | $66,421 | $5,564 | 8.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2023 | 98 | 107 | $63,799 | $4,269 | 6.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 23 | 23 | $9,074 | $2,079 | 22.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 28 | 28 | $7,512 | $1,601 | 21.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Facility | 2023 | 13 | 16 | $15,048 | $1,229 | 8.2% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2023 | 51 | 52 | $27,885 | $852.95 | 3.1% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Facility | 2023 | 32 | 33 | $4,924 | $799.52 | 16.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2023 | 118 | 475 | $14,288 | $597.53 | 4.2% |
| 11104 | Punch biopsy, first skin growth | Facility | 2023 | 16 | 16 | $10,788 | $500.25 | 4.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Facility | 2023 | 13 | 18 | $5,200 | $271.70 | 5.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 321 | 373 | $58,106 | $15,828 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 168 | 211 | $49,912 | $14,054 | 28.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2022 | 205 | 232 | $77,848 | $6,702 | 8.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2022 | 111 | 120 | $66,870 | $4,771 | 7.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 44 | 44 | $11,032 | $2,280 | 20.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 23 | 23 | $8,477 | $2,229 | 26.3% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2022 | 118 | 127 | $63,627 | $2,212 | 3.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Facility | 2022 | 20 | 24 | $17,496 | $1,462 | 8.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 20 | $6,679 | $1,068 | 16.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2022 | 142 | 612 | $17,216 | $846.76 | 4.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Facility | 2022 | 36 | 54 | $14,580 | $834.44 | 5.7% |
| 11104 | Punch biopsy, first skin growth | Facility | 2022 | 25 | 26 | $17,010 | $820.28 | 4.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Facility | 2022 | 11 | 11 | $9,669 | $787.50 | 8.1% |
About Dr. Maggie Moses, M.D
Dr. Maggie Moses, M.D is a Dermatology healthcare provider based in Marshfield, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2015. The National Provider Identifier (NPI) number assigned to this provider is 1073908398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maggie Moses, M.D has received a total of $124.98 in payments from pharmaceutical and medical device companies, with $124.98 received in 2018. These payments were reported across 1 transactions from 1 company. The most common payment nature is "Food and Beverage" ($124.98).
As a Medicare-enrolled provider, Moses has provided services to 2,480 Medicare beneficiaries, totaling 3,687 services with total Medicare billing of $105,531. Data is available for 3 years (2021–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Marshfield, WI
- Active Since 04/02/2015
- Last Updated 12/21/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1073908398
Products in Payments
- EUCRISA (Drug) $124.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.